Qu Biologics Inc. Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryQu Biologics Inc. Qu Biologics is a biotechnology company that develops the site specific immunotherapy a proprietary technology platform that is designed to treat immunerelated diseases and...
View ArticleEnsemble Therapeutics Corporation Pharmaceuticals Healthcare Deals and...
SummaryEnsemble Therapeutics Corporation Ensemble is a biotechnology company that provides therapeutics and diagnostics for oncology therapy. The company is developing Ensemblins which is a synthetic...
View ArticleFred Hutchinson Cancer Research Center Pharmaceuticals Healthcare Deals and...
SummaryFred Hutchinson Cancer Research Center Fred Hutchinson is a nonprofit organization that research on the prevention diagnose and treatment of cancer HIVAIDS and other life threatening diseases....
View ArticleGrand Opening of Northwestern Medicine Digestive Health Center
CHICAGO Nov. 18 2016 PRNewswireUSNewswire Dr. Stephen B. Hanauer and Dr. Scott A. Strong unveil the new stateoftheart Digestive Health Center DHC at Northwestern Medicine's Lavin Family Pavilion 259 E....
View ArticleSequella Inc. Pharmaceuticals Healthcare Deals and Alliances Profile Prices...
SummarySequella Inc. Sequella is a biopharmaceutical company that develops and commercializes products for diagnosis and treatment of infectious diseases. The company is developing antibiotics for...
View ArticleNatco Pharma Limited NATCOPHARM Financial and Strategic SWOT Analysis Review...
Natco Pharma Limited NATCOPHARM Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleTxCell SA TXCL Pharmaceuticals Healthcare Deals and Alliances Profile Prices...
SummaryTxcell SA Txcell is a biotechnology company that develops and innovates cellbased immunotherapy utilizing antigen specific regulatory Tcells with focus on chronic inflammatory and autoimmune...
View ArticleCelltrion Inc. 068270 Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryCelltrion Inc. Celltrion is a biopharmaceutical company that focuses on research development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies...
View ArticleAmpio Pharmaceuticals Inc. AMPE Pharmaceuticals Healthcare Deals and...
SummaryAmpio Pharmaceuticals Inc. Ampio formerly Chay Enterprises Inc. is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company...
View ArticleMore insight into Crohn's disease
Researchers Robil Naziroglu and Frans Vos have developed a method for improving the assessment of MRI images in cases of Crohn's disease. In time this may well enable more targeted monitoring and...
View ArticleAmPharma B.V. Pharmaceuticals Healthcare Deals and Alliances Profile Prices...
SummaryAMPharma B.V. AMPharma is a biopharmaceutical company. It undertakes the preclinical and clinical development of recombinant human alkaline phosphatase therapeutics for the treatment of...
View ArticleRedHill Biopharma Announces YELIVA ABC294640 Poster Presentation at the 2016...
The poster to be presented at the upcoming EORTCNCIAACR Molecular Targets and Cancer Therapeutics Symposium describes results from nonclinical studies conducted by Apogee Biotechnology Corp....
View ArticleEnzon Pharmaceuticals Inc. ENZN Financial and Strategic SWOT Analysis Review...
Enzon Pharmaceuticals Inc. ENZN Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleCalciMedica Inc. Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryCalciMedica Inc. CalciMedica is a pharmaceutical company that discovers and develops small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant...
View ArticleImmune Pharmaceuticals Announces ImmunoOncology R&D Update on December 8 2016
NEW YORK Nov. 22 2016 PRNewswire Immune Pharmaceuticals NASDAQ IMNP Immune announced today that it will hold an ImmunoOncology R&D Update for investors on December 8 2016 in New York City....
View ArticleTofacitinib for Refractory Esophageal Crohn's Disease
The positive results in this case suggest that the novel biologic tofacitinib may be effective as an alternative therapy for refractory esophageal Crohn's disease. Journal of Medical Case Reports
View ArticleOver 80 Research Abstracts to be Presented & Record Attendance Expected at...
NEW YORK Nov. 22 2016 PRNewswireUSNewswire The Crohn's & Colitis Foundation of America CCFA and Imedex will present a record number of research abstracts at the 2016 Crohn's & Colitis...
View ArticleBRIEFPhase 3 study with filgotinib initiated in crohn's disease
Galapagos NV says start of diversity study triggers a $50million milestone payment from GileadSource text for Eikon Further company coverage
View ArticleGalapagos NV Phase 3 study with filgotinib initiated in Crohn's disease
First patient dosed triggers $50 million milestone payment Mechelen Belgium; 22 November 2016 Galapagos NV Euronext & NASDAQ GLPG reports the first dosing of a patient in the DIVERSITY Phase...
View ArticlePhase 3 study with filgotinib initiated in Crohn's disease
  First patient dosed triggers $50 million milestone payment Mechelen Belgium; 22 November 2016 Galapagos NV Euronext & NASDAQ GLPG reports the first dosing of a patient in the DIVERSITY...
View Article